Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial respiratory chain and energy-metabolism enzymes are a collection of multi-subunit protein complexes (Complex I through V) and auxiliary enzymes located in the inner mitochondrial membrane and matrix. These enzymes facilitate oxidative phosphorylation, the process of generating adenosine triphosphate (ATP) by transferring electrons from NADH and FADH2 to molecular oxygen while pumping protons to create an electrochemical gradient (StatPearls, PMID: 30725950). This system is essential for cellular energy homeostasis, but it also serves as a major source of reactive oxygen species and a key regulator of programmed cell death (PubMed, PMID: 15864337). Mutations or functional impairments in these enzymes lead to primary mitochondrial diseases, such as Leigh syndrome, and contribute to the pathogenesis of neurodegenerative conditions, diabetes, and cancer (NIH, GARD). Therapeutic strategies targeting these enzymes include the use of inhibitors like metformin to modulate systemic metabolism or bypass agents like idebenone to restore electron flow in deficient states (PubMed, PMID: 21701597). However, targeting these fundamental metabolic pathways carries significant risks, including lactic acidosis and systemic toxicity due to the vital role of mitochondria in nearly all eukaryotic cells. Monitoring efficacy and safety often involves measuring metabolic byproducts like lactate or assessing mitochondrial function through oxygen consumption rates. Overall, this target class represents a critical node in cellular metabolism with broad implications for human health and disease.
Inhibition of electron transport chain complexes, uncoupling of oxidative phosphorylation, and restoration of electron flow through redox bypass.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial respiratory chain and energy-metabolism enzymes (MRC).